Stoichiometry of N-methyl-D-aspartate receptors within the suprachiasmatic nucleus.
The circadian pacemaker within the suprachiasmatic nucleus (SCN) confers daily rhythms to bodily functions. In nature, the circadian clock will adopt a 24-h period by synchronizing to the solar light/dark cycle. This light entrainment process is mediated, in part, at glutamatergic synapses formed between retinal ganglion afferents and SCN neurons. N-methyl-D-aspartate receptors (NMDARs) located on SCN neurons gate light-induced phase resetting. Despite their importance in circadian physiology, little is known about their functional stoichiometry. We investigated the NR2-subunit composition with whole cell recordings of SCN neurons within the murine hypothalamic brain slice using a combination of subtype-selective NMDAR antagonists and voltage-clamp protocols. We found that extracellular magnesium ([Mg](o)) strongly blocks SCN NMDARs exhibiting affinities and voltage sensitivities associated with NR2A and NR2B subunits. These NMDAR currents were inhibited strongly by NR2B-selective antagonists, Ro 25-6981 (3.5 microM, 55.0 +/- 9.0% block; mean +/- SE) and ifenprodil (10 microM, 55.8 +/- 3.0% block). The current remaining showed decreased [Mg](o) affinities reminiscent of NR2C and NR2D subunits but was highly sensitive to [Zn](o), a potent NR2A blocker, showing a approximately 44.2 +/- 1.1% maximal inhibition at saturating concentrations with an IC(50) of 7.8 +/- 1.1 nM. Considering the selectivity, efficacy, and potency of the drugs used in combination with [Mg](o)-block characteristics of the NMDAR, our data show that both diheteromeric NR2B NMDARs and triheteromeric NR2A NMDARs (paired with an NR2C or NR2D subunits) account for the vast majority of the NMDAR current within the SCN.
Clark
J P
JP
Department of Neuroscience, University of Minnesota, 6-145 Jackson Hall, 321 Church St. SE, Minneapolis, MN 55455, USA.
Kofuji
P
P
D000818:Animals; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D066298:In Vitro Techniques; D008274:Magnesium / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D009474:Neurons / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D018408:Patch-Clamp Techniques / Q000379:methods; D010636:Phenols / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D021122:Protein Subunits / Q000378:metabolism; D016194:Receptors, N-Methyl-D-Aspartate / Q000737:chemistry / Q000378:metabolism*; D013493:Suprachiasmatic Nucleus / Q000166:cytology* / Q000378:metabolism
D018691:Excitatory Amino Acid Antagonists; D010636:Phenols; D010880:Piperidines; D021122:Protein Subunits; D016194:Receptors, N-Methyl-D-Aspartate; C109643:Ro 25-6981; D008274:Magnesium; C010739:ifenprodil
Nature. 1984 Feb 2-8;307(5950):462-5
6320006
J Neurosci. 1994 Oct;14(10):6102-20
7931566
Neuron. 1999 May;23(1):171-80
10402203
Nature. 2002 Feb 14;415(6873):793-8
11823786
J Neurosci Res. 2000 Sep 15;61(6):663-73
10972963
Brain Res. 1999 Aug 7;837(1-2):106-16
10433993
Brain Res. 1988 Sep 20;460(2):297-313
2465060
J Pharmacol Exp Ther. 1997 Dec;283(3):1285-92
9400004
Brain Res. 1986 Jul 30;379(1):176-81
3742212
J Neurosci. 1999 Jun 15;19(12):5124-30
10366645
J Neuroendocrinol. 1999 Jan;11(1):43-51
9918228
J Neurosci. 2005 Jan 12;25(2):308-17
15647474
Neuroscience. 2003;119(1):137-44
12763075
J Gen Physiol. 1973 Jun;61(6):687-708
4541078
Mol Pharmacol. 1995 Nov;48(5):841-8
7476914
Neurosci Lett. 1994 Jul 18;176(1):59-62
7970238
J Neurosci. 1995 Oct;15(10):6509-20
7472413
J Pharmacol Exp Ther. 1997 Jul;282(1):326-38
9223571
J Neurosci. 2006 Oct 18;26(42):10899-910
17050728
Brain Res Mol Brain Res. 1994 Jun;23(4):338-44
8090074
Prog Neurobiol. 1996 Oct;50(2-3):109-32
8971980
Eur J Neurosci. 2006 Aug;24(4):1109-16
16930436
Neuroreport. 1996 Apr 26;7(6):1224-8
8817537
Neuroscience. 2009 Mar 17;159(2):599-609
19361480
BMC Neurosci. 2006 Feb 16;7:15
16483357
Cell Tissue Res. 2002 Jul;309(1):73-88
12111538
J Pharmacol Exp Ther. 2007 Aug;322(2):739-48
17502428
Neurosci Lett. 1995 Jan 30;184(3):181-4
7715842
Science. 2002 Feb 8;295(5557):1065-70
11834834
J Comp Neurol. 1993 Dec 15;338(3):377-90
8113446
Neuroscience. 2002;113(1):37-45
12123682
J Neurosci. 2005 Oct 5;25(40):9304-8
16207890
J Neurosci. 2001 Feb 15;21(4):1228-37
11160393
Science. 1992 Mar 20;255(5051):1581-4
1549784
J Physiol. 1999 Nov 15;521 Pt 1:99-111
10562337
Neuron. 2005 Apr 21;46(2):261-74
15848804
Brain Res. 1994 Apr 18;643(1-2):296-301
8032923
Eur J Neurosci. 2001 Apr;13(7):1420-8
11298803
J Neurosci. 2002 Jul 15;22(14):5955-65
12122058
Nat Neurosci. 1998 Dec;1(8):659-67
10196581
Mol Pharmacol. 1993 Oct;44(4):851-9
7901753
J Neurosci. 1997 Jan 15;17(2):667-75
8987789
Science. 1993 Apr 9;260(5105):238-41
8097062
J Neurosci Res. 2006 Nov 15;84(7):1512-20
16983663
Science. 2002 Feb 8;295(5557):1070-3
11834835
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):11062-7
10984504
J Physiol. 2001 Apr 1;532(Pt 1):181-94
11283234
Am J Physiol Regul Integr Comp Physiol. 2005 Sep;289(3):R656-62
15860648
J Neurosci. 1999 Aug 1;19(15):6637-42
10414992
J Neurophysiol. 2008 Jan;99(1):122-32
18003876
J Neurosci. 1997 Aug 1;17(15):5711-25
9221770
J Physiol. 1996 Dec 15;497 ( Pt 3):761-72
9003561
Nature. 1998 May 28;393(6683):377-81
9620802
J Biol Rhythms. 1992 Summer;7(2):125-36
1611128
J Biol Chem. 1993 Feb 5;268(4):2836-43
8428958
J Biol Chem. 2003 Jan 3;278(1):276-83
12414797
Curr Opin Neurobiol. 2001 Jun;11(3):336-42
11399432
Mol Pharmacol. 2002 Nov;62(5):1119-27
12391275
J Neurosci. 1995 Oct;15(10):6498-508
7472412
Mol Pharmacol. 2007 Oct;72(4):907-20
17622578
Eur J Neurosci. 2003 Jan;17(1):58-70
12534969
J Neurosci. 1996 Jun 1;16(11):3549-58
8642401
Neurosci Lett. 1996 Aug 30;215(1):9-12
8880741
J Neurophysiol. 2002 Apr;87(4):2052-63
11929923
Nat Neurosci. 2001 Sep;4(9):894-901
11528420
Brain Res Mol Brain Res. 1995 Feb;28(2):239-50
7723623
Sci STKE. 2004 Oct 19;2004(255):re16
15494561
Neuron. 1990 Aug;5(2):127-34
2116813
J Neurochem. 2001 Oct;79(1):161-71
11595768
Brain Res. 1997 May 30;758(1-2):245-9
9203556
Eur J Neurosci. 2008 Apr;27(7):1771-9
18380671
Neuron. 2000 Dec;28(3):911-25
11163276
Science. 1994 Dec 9;266(5191):1713-7
7527589
Nat Rev Neurosci. 2007 Oct;8(10):790-802
17882255
Brain Res. 1993 Dec 31;632(1-2):329-33
8149240
Am J Physiol. 1994 Aug;267(2 Pt 2):R360-4
7520671
Mol Pharmacol. 2000 Dec;58(6):1554-62
11093796
Nature. 1992 Jul 2;358(6381):36-41
1377365
Neurosci Lett. 1994 Jan 31;166(2):211-5
8177501